Aranesp is a medicine used to treat anaemia (low red blood cell counts) that is causing symptoms. It is used in two groups of patients: * adults and children with chronic renal failure (long\-term, decreasing in the ability of the kidneys to work properly); * adults who are receiving chemotherapy for non‑myeloid cancer (cancer not originating in the bone marrow). Aranesp contains the active substance darbepoetin alfa.
Therapeutic Indication
Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients. Treatment of symptomatic anaemia in adult cancer patients with non\-myeloid malignancies receiving chemotherapy.
Therapeutic Area (MeSH)
ATC Code
B03XA02
ATC Item
N/A
Pharmacotherapeutic Group
Other antianemic preparations
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| darbepoetin alfa | N/A | darbepoetin alfa |
EMA Name
Aranesp
Medicine Name
Aranesp
Aliases
N/ANo risk management plan link.
